Icon

IGALMI (nda215390)- (EQ 0.12MG BASE,EQ 0.18MG BASE)

DEXMEDETOMIDINE HYDROCHLORIDE BIOXCEL
EQ 0.12MG BASE,EQ 0.18MG BASE
No Yes
2043-Jan-12 Expired
None 2025-Apr-05
None No
IGALMI is an alpha2-adrenergic receptor agonist indicated in adults for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
0 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 0.12MG BASE ** ** - - -
EQ 0.18MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.